Abstract:Transgenic expression of Cre recombinase driven by a specific promoter is normally used to conditionally knockout a gene in a tissue- or cell-type-specific manner. In αMHC-Cre transgenic mouse model, expression of Cre recombinase is controlled by the myocardial-specific α-myosin heavy chain (αMHC) promoter, which is commonly used to edit myocardial-specific genes. Toxic effects of Cre expression have been reported, including intro-chromosome rearrangements, micronuclei formation and other forms of DNA damage, and cardiomyopathy was observed in cardiac-specific Cre transgenic mice. However, mechanisms associated with Cardiotoxicity of Cre remain poorly understood. In our study, our data unveiled that αMHC-Cre mice developed arrhythmias and died after six months progressively, and none of them survived more than one year. Histopathological examination showed that αMHC-Cre mice had aberrant proliferation of tumor-like tissue in the atrial chamber extended from and vacuolation of ventricular myocytes. Furthermore, the αMHC-Cre mice developed severe cardiac interstitial and perivascular fibrosis, accompanied by significant increase of expression levels of MMP-2 and MMP-9 in the cardiac atrium and ventricular. Moreover, cardiac-specific expression of Cre led to disintegration of the intercalated disc, along with altered proteins expression of the disc and calcium-handling abnormality. Comprehensively, we identified that the ferroptosis signaling pathway is involved in heart failure caused by cardiac-specific expression of Cre, on which oxidative stress results in cytoplasmic vacuole accumulation of lipid peroxidation on the myocardial cell membrane. Taken together, these results revealed that cardiac-specific expression of Cre recombinase can lead to atrial mesenchymal tumor-like growth in the mice, which causes cardiac dysfunction, including cardiac fibrosis, reduction of the intercalated disc and cardiomyocytes ferroptosis at the age older than six months in mice. Our study suggests that αMHC-Cre mouse models are effective in young mice, but not in old mice. Researchers need to be particularly careful when using αMHC-Cre mouse model to interpret those phenotypic impacts of gene responses. As the Cre-associated cardiac pathology matched mostly to that of the patients, the model could also be employed for investigating age-related cardiac dysfunction.

Myocardial Overexpression of Mecr, A Gene of Mitochondrial Fas Ii Leads to Cardiac Dysfunction in Mouse

Characterization of the 2-Enoyl Thioester Reductase of Mitochondrial Fatty Acid Synthesis Type II in Mammals

Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice

Cardiac-Specific Overexpression of ERRγ in Mice Induces Severe Heart Dysfunction and Early Lethality

Selective enhancement of cardiomyocyte efficiency results in a pernicious heart condition

Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy

Cardiac-Specific Expression of Cre Recombinase Leads to Age-Related Cardiac Dysfunction Associated with Tumor-like Growth of Atrial Cardiomyocyte and Ventricular Fibrosis and Ferroptosis

A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels

Mitochondrial fission process 1 (MTFP1) controls bioenergetic efficiency and prevents inflammatory cardiomyopathy and heart failure in mice

A novel mouse model of lipotoxic cardiomyopathy

A human mitofusin 2 mutation can cause mitophagic cardiomyopathy

Abstract 1681: Haploinsufficiency of MEF2A Increases Risk of Atherosclerosis in Mice

Myocardin-related transcription factor A, regulated by serum response factor, contributes to diabetic cardiomyopathy in mice.

Myocardium-specific Isca1 knockout causes iron metabolism disorder and myocardial oncosis in rat

Mitochondrial fusion mediated by fusion promotion and fission inhibition directs adult mouse heart function toward a different direction.

Forced expression of miR-143 and -145 in cardiomyocytes induces cardiomyopathy with a reductive redox shift

Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis

Knockdown Expression of MECR, a Novel Gene of Mitochondrial FAS II Inhibits Growth and Colony-Formation, Promotes Apoptosis of Hepatocelluar Carcinoma Cells.

Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations

TECRL deficiency results in aberrant mitochondrial function in cardiomyocytes

Mitofusin-2 is a Major Determinant of Oxidative Stress-mediated Heart Muscle Cell Apoptosis